Physician profile
Derick M Johnson
NPI 1972768232
$255,740.57
in general payments reported to CMS, 2019-2025
9 companies · $31K in 2025
The $31K reported for 2025 was more than what 93% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $62K · 2020: $44K · 2021: $56K · 2022: $26K · 2023: $4,160 · 2024: $33K · 2025: $31K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $61K · Travel and Lodging: $5,734 · Food and Beverage: $895.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $61,425.00 |
| Travel and Lodging | $5,734.17 |
| Food and Beverage | $894.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $255,498.58 | 2019-2025 | Mako, Aequalis, Gmrs |
| Zimmer Biomet Holdings, INC. | $48.60 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $47.82 | 2021 | |
| Medwest Associates | $41.63 | 2023 | |
| Pacira Pharmaceuticals Incorporated | $30.73 | 2022-2025 | Iovera, Zilretta |
| Bioventus LLC | $28.06 | 2019-2021 | |
| Heraeus Medical, LLC. | $19.04 | 2025 | |
| Convatec INC. | $15.14 | 2019 | |
| Pacira Therapeutics, INC. | $10.97 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Derick Johnson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.